Bausch + Lomb Corporation
TSX:BLCO.TO · Toronto Stock Exchange
+$0.04 today
Vol 0.00M · Avg 0.00M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $278.3M |
| Receivables | $1.1B |
| Inventory | $974.5M |
| Other Current | $412.9M |
| Total Current Assets | $2.8B |
| PP&E (Net) | $1.8B |
| Goodwill | $4.7B |
| Intangible Assets | $3.2B |
| Tax Assets | $942.6M |
| Other Non-current | $301.2M |
| Total Non-current Assets | $11.0B |
| Total Assets | $13.7B |
Analysis
Selected assets total $13.7B for Latest. The largest visible component is Goodwill at $4.7B, about 34.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $397.0M +30.2% | $305.0M -7.9% | $331.0M -6.5% | $354.0M +103.4% | $174.0M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $1.2B +19.1% | $1.0B +22.3% | $839.0M +15.9% | $724.0M +0.4% | $721.0M | $533.8M | $399.4M | -$1.7B |
| Inventory | $976.0M -5.8% | $1.0B +0.8% | $1.0B +63.7% | $628.0M +9.8% | $572.0M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $382.0M -9.3% | $421.0M +815.2% | $46.0M -63.8% | $127.0M +4133.3% | $3.0M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $3.0B +6.8% | $2.8B +1.7% | $2.7B +28.3% | $2.1B +30.7% | $1.6B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $1.9B +29.4% | $1.5B -1.3% | $1.5B +15.7% | $1.3B +6.1% | $1.2B | $1.2B | $1.5B | $687.8M |
| Goodwill | $4.8B +5.2% | $4.5B -1.1% | $4.6B +1.5% | $4.5B -1.7% | $4.6B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $3.3B -6.1% | $3.5B -2.6% | $3.6B +74.4% | $2.1B -9.1% | $2.3B | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $7.0M | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $934.0M +5.5% | $885.0M -3.9% | $921.0M -0.6% | $927.0M -0.6% | $933.0M | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $143.0M -51.4% | $294.0M -71.5% | $1.0B +380.0% | $215.0M +19.4% | $180.0M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $11.0B +3.4% | $10.7B -0.2% | $10.7B +18.8% | $9.0B -2.0% | $9.2B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $14.0B +4.1% | $13.5B +0.2% | $13.4B +20.6% | $11.1B +3.0% | $10.8B | $13.3B | $11.9B | $10.6B |
| Account Payables | $388.0M -0.3% | $389.0M -25.5% | $522.0M +41.1% | $370.0M +54.8% | $239.0M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $77.0M +92.5% | $40.0M +33.3% | $30.0M +20.0% | $25.0M -10.7% | $28.0M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 +100.0% | -$28.0M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $1.2B +90.4% | $633.0M +35.8% | $466.0M +16.2% | $401.0M +6.6% | $376.0M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $1.9B +10.5% | $1.7B +10.1% | $1.6B +21.8% | $1.3B +17.9% | $1.1B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $5.2B +8.9% | $4.7B +4.7% | $4.5B +88.0% | $2.4B | $0 | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $19.0M +46.2% | $13.0M -7.1% | $14.0M +100.0% | $7.0M -70.8% | $24.0M | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 +100.0% | -$92.0M | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $271.0M -37.0% | $430.0M +32.7% | $324.0M +32.8% | $244.0M -24.2% | $322.0M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $5.6B +7.6% | $5.2B +4.9% | $4.9B +79.9% | $2.7B +753.1% | $322.0M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $7.5B +8.3% | $6.9B +6.2% | $6.5B +61.3% | $4.0B +184.5% | $1.4B | $14.7B | $3.7B | $9.6B |
| Common Stock | $0 | $0 | $0 | $0 -100.0% | $10.4B | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$931.0M -63.0% | -$571.0M -124.8% | -$254.0M -4333.3% | $6.0M | $0 | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$1.2B +14.5% | -$1.4B -11.2% | -$1.2B +1.0% | -$1.3B -21.5% | -$1.0B | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $71.0M -0.0% | $71.0M +1.4% | $70.0M +2.9% | $68.0M -6.8% | $73.0M | $1.4B | $337.8M | $931.4M |
| Total Equity | $6.5B -0.4% | $6.5B -5.4% | $6.9B -2.5% | $7.1B -24.5% | $9.4B | $9.1B | $7.7B | $3.3B |
| Total Debt | $5.4B +12.2% | $4.8B +4.9% | $4.6B +87.3% | $2.4B +8600.0% | $28.0M | $724.2M | $410.6M | $399.4M |
| Net Debt | $5.0B +11.0% | $4.5B +5.9% | $4.2B +103.2% | $2.1B +1526.0% | -$146.0M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Curaleaf Holdings, Inc.
TSX:CURA.TO
$3.12B
Trulieve Cannabis Corp.
TRUL.CN
$2.74B
Bausch Health Companies Inc.
TSX:BHC.TO
$2.51B
WELL Health Technologies Corp.
TSX:WELL.TO
$1.12B
Tilray Brands, Inc.
TSX:TLRY.TO
$801.35M
Spectral Medical Inc.
TSX:EDT.TO
$404.92M
Fennec Pharmaceuticals Inc.
TSX:FRX.TO
$366.40M
Zentek Ltd.
ZEN.V
$66.14M
Sona Nanotech Inc.
SONA.CN
$32.60M
Ocumetics Technology Corp.
OTC.V
$30.63M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does BLCO.TO have?
Bausch + Lomb Corporation (BLCO.TO) reported $397.00M in cash and equivalents in fiscal 2025.
How much debt does BLCO.TO carry?
Bausch + Lomb Corporation (BLCO.TO) reported $5.37B of total debt, with net debt of $4.97B.
Explore More
Continue the stock analysis
Jump to another research area for this company.